# Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial

> **NCT04875026** · PHASE4 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 146 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** 5-fluorouracil 4% (Tolak)
- **DEVICE:** Dexeryl

## Key facts

- **NCT ID:** NCT04875026
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-16
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2022-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04875026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04875026, "Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04875026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*